Abstract
Quinacrine (QC), an FDA-approved anti-malarial drug, has shown to have anticancer activities. Due to its ‘shotgun’ nature, QC has become an inevitable candidate for combination chemotherapy. There is lack of study of the molecular interplay between colorectal cancer (CRC) microenvironment and its metastasis. In this study, we focused on the differential anti-cancerous effect of QC on two different human cancer cell lines, HCT 116 and INT 407. Results suggest that cytotoxicity increased in both the cell lines with an increase in QC concentration. The expression patterns of small-GTPases and caspases were altered significantly in QC-treated cells compared to non-treated cells. HSP70 and p53 showed comparable differences in the expression pattern. The wound-healing assay showed an increase in the denuded zone, with an increase in the concentration of QC. The formation of apoptotic nuclei increased with a rise in the concentration of QC in both the cell lines. The decrease and increase in caspase 9 and caspase 3 expression respectively were studied, confirming apoptosis by the extrinsic pathway.

















Similar content being viewed by others
References
Ashkenazi A 2008 Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat. Rev. Drug Discov. 7 1001
Baskić D, Popović S, Ristić P and Arsenijević NN 2006 Analysis of cycloheximide‐induced apoptosis in human leukocytes: Fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol. Int. 30 924–932
Celisa Santimano M, Martin A, Kowshik M and Sarkar A 2013 Zinc oxide nanoparticles cause morphological changes in human A549 cell line through alteration in the expression pattern of small GTPases at mRNA level. J. Bionanosci. 7 300–306
Cheng YT, Lin JA, Jhang JJ and Yen GC 2019 Protocatechuic acid-mediated DJ-1/PARK7 activation followed by PI3K/mTOR signaling pathway activation as a novel mechanism for protection against ketoprofen-induced oxidative damage in the gastrointestinal mucosa. Free Radic. Biol. 130 35–47
Chowdhury I, Tharakan B and Bhat GK 2006 Caspases—an update. Comp. Biochem. Phys. B Biochem. Mol Bio. 151 10–27
de Lira Mota KS, Dias GEN, Pinto MEF, Luiz Ferreira Â, Monteiro Souza-Brito AR, Hiruma-Lima CA, Barbosa-Filho JM and Batista LM 2009 Flavonoids with gastroprotective activity. Molecules 14 979–1012
Ehsanian R, Van Waes C and Feller SM 2011 Beyond DNA binding-a review of the potential mechanisms mediating quinacrine’s therapeutic activities in parasitic infections, inflammation, and cancers. Cell Commun. Signal. 9 13
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC 1992 Induction of apoptosis in fibroblasts by c-myc protein. Cell 69 119–128
Fasanmade AA, Owuor ED, Ee RP, Qato D, Heller M and Kong ANT 2001 Quinacrine induces cytochrome c-dependent apoptotic signaling in human cervical carcinoma cells. Arch. Pharm. Res. 24 126–135
Friedl P and Wolf K 2003 Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3 362
Fritz G, Just I and Kaina B 1999 Rho GTPases are over‐expressed in human tumors. Int. J. Cancer. 81 682–687
Goodell JR, Ougolkov AV, Hiasa H, Kaur H, Remmel R, Billadeau DD and Ferguson DM 2008 Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis. J. Med. Chem. 51 179–182
Grady WM and Carethers JM 2008 Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135 1079–1099
Gupta SK, Croffie JM, Pfefferkorn MD and Fitzgerald JF 2003 Diagnostic yield of duodenal aspirate for G. lamblia and comparison to duodenal mucosal biopsies. Dig. Dis. Sci. 48 605–607
Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, Samoylova E, Khodyakova AV, Ganapathi R, Ganapathi M, Tararova ND and Bosykh D 2005 Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors. Proc. Natl. Acad. Sci. USA 102 17448–17453
Gurova K 2009 New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents. Futur. Oncol. 5 1685–1704
Hall A 2009 The cytoskeleton and cancer. Cancer Metastasis Rev. 28 5–14
Harikumar KB, Kuttan G and Kuttan R 2009 Phyllanthus amarus inhibits cell growth and induces apoptosis in Dalton’s lymphoma ascites cells through activation of caspase-3 and downregulation of Bcl-2. Integr. Cancer Ther. 8 190–194
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D 2011 Global cancer statistics. CA Cancer J. Clin. 61 69–90
Jeong HS, Choi Y, Lee ER, Kim JH, Jeon K, Lee HJ and Cho SG. 2011. Involvement of caspase-9 in autophagy-mediated cell survival pathway. Biochim. Biophys. Acta Mol. Cell Res. 1813 80–90
Jin Z and El-Deiry WS 2005 Overview of cell death signaling pathways. Cancer. Biol. Ther. 4 147–171
Kominami K, Nakabayashi J, Nagai T, Tsujimura Y, Chiba K, Kimura H, Miyawaki A, Sawasaki T, Yokota H, Manabe N and Sakamaki K 2012 The molecular mechanism of apoptosis upon caspase-8 activation: Quantitative experimental validation of a mathematical model. Biochim. Biophys. Acta Mol. Cell Res. 1823 1825–1840
Lalitha P, Veena V, Vidhyapriya P, Lakshmi P, Krishna R and Sakthivel N 2016 Anticancer potential of pyrrole (1, 2, a) pyrazine 1, 4, dione, hexahydro 3-(2-methyl propyl) (PPDHMP) extracted from a new marine bacterium, Staphylococcus sp. strain MB30. Apoptosis 21 566–577
Lozano E, Betson M and Braga VM 2003 Tumor progression: small GTPases and loss of cell–cell adhesion. Bioessays 25 452–463
Maity P, Biswas K, Roy S, Banerjee RK and Bandyopadhyay U 2003 Smoking and the pathogenesis of gastroduodenal ulcer–recent mechanistic update. Mol. Cell. Biochem. 253 329–338
Moghaddam DD, Ghadirian E and Azami M 2005 Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. Parasitol. Res. 96 273–275
Ortega YR and Adam RD 1997 Giardia: overview and update. Clin. Infect. Dis. 25 545–549
Pancione M, Remo A and Colantuoni V 2012 Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog. Res. Int. 2012 11
Paul-Samojedny M, Kokocińska D, Samojedny A, Mazurek U, Partyka R, Lorenz Z and Wilczok T 2005 Expression of cell survival/death genes: Bcl-2 and Bax at the rate of colon cancer prognosis Biochim. Biophys. Acta Mol. Basis Dis. 1741 25–29
Pertz O, Hodgson L, Klemke RL and Hahn KM 2006 Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 440 1069
Preet R, Mohapatra P, Mohanty S, Sahu SK, Choudhuri T, Wyatt MD and Kundu CN 2012 Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity. Int. J. Cancer 130 1660–1670
Sander EE, van Delft S, Jean P, Reid T, van der Kammen RA, Michiels F and Collard JG 1998 Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell–cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143 1385–1398
Sarkar A, Parikh N, Hearn SA, Fuller MT, Tazuke SI and Schulz C 2007 Antagonistic roles of Rac and Rho in organizing the germ cell microenvironment. Curr. Biol. 17 1253–1258
Tahir AA, Sani NFA, Murad NA, Makpol S, Ngah WZW and Yusof YAM 2015 Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT29 cells. Nutr. J. 14 31
Torres RE M, Banegas EI, Mendoza M, Diaz C, Bucheli ST M, Fontecha GA, Alam MT, Goldman I, Udhayakumar V and Zambrano JON 2013 Efficacy of chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in Honduras. Am. J. Trop. Med. Hyg. 88 850–854
Upcroft P and Upcroft JA 2001 Drug targets and mechanisms of resistance in the anaerobic protozoa Clin. Micro. Revs. 14 150–164
Van Hengel J, D’Hooge P, Hooghe B, Wu X, Libbrecht L, De Vos R, Quondamatteo F, Klempt M, Brakebusch C and Van Roy F 2008 Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver. Gastroenterology 134 781–792
Wang G, Wang X, Yu H, Wei S, Williams N, Holmes DL, Halfmann R, Naidoo J, Wang L, Li L and Chen S 2013 Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nat. Chem. Biol. 9 84
Wiezorek J, Holland P and Graves J 2010 Death receptor agonists as a targeted therapy for cancer. Clin. Cancer Res. 16 1701–1708
Xu YQ, Zhang JH and Yang XS 2016 Corosolic acid induces potent anti-cancer effects in CaSki cervical cancer cells through the induction of apoptosis, cell cycle arrest and PI3K/Akt signalling pathway. Bangladesh J. Pharmacol. 11 453–459
Acknowledgements
AS acknowledges the financial support for this work to DBT, India, as a pilot project grant [Grant No. 6242-P59/RGCB/PMD/DBT/ANSR/2015]. AS was supported by a fellowship from the same grant. The author acknowledges Prof. Utpal Roy for proofreading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Sorab Dalal.
Corresponding editor: Sorab Dalal
Rights and permissions
About this article
Cite this article
Samanta, A., Ravindran, G. & Sarkar, A. Quinacrine causes apoptosis in human cancer cell lines through caspase-mediated pathway and regulation of small-GTPase. J Biosci 45, 43 (2020). https://doi.org/10.1007/s12038-020-0011-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12038-020-0011-3